Since its discovery in the late 1950s Coenzyme Q10
(CoQ10) has received much attention as a necessary compound for proper cellular
function. It is the essential coenzyme necessary for the production of ATP
(adenosine triphosphate) upon which all cellular functions depend. Without ATP
our bodies cannot function properly. Without CoQ10, ATP cannot function. This
connection has made CoQ10 a very important object of study in relation to
chronic disease.
In many cases the presence of chronic disease is
associated with inadequate levels of CoQ10. But no area of study has received
more attention than the relation between CoQ10 and heart disease. That is
because CoQ10 is believed to be of fundamental importance in cells with high
metabolic demands such as cardiac cells. A further reason the connection of
heart disease and CoQ10 has gained so much attention is because heart
conditions of many kinds are associated with chronically low CoQ10 levels.
CoQ10 is highly concentrated in heart muscle cells
because of their high energy requirements. Add this to the fact that heart
disease is the number one killer in developed and developing countries and one
can see why the bulk of scientific research on CoQ10 has been concerned with
heart disease. Specifically, studies on congestive heart failure have
demonstrated a strong correlation between the severity of heart failure and the
degree of CoQ10 deficiency. The lower the levels of CoQ10 in the heart muscles
the more severe the heart failure. If indeed CoQ10 deficiency is a primary
cause of congestive heart failure then, in such cases, the remedy is simple and
cost effective; CoQ10 supplementation.
Congestive heart failure is a condition where the heart
does not pump effectively resulting in an accumulation of fluid in the lungs.
Symptoms may include shortness of breath, difficulty breathing when lying flat
and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy
(primary heart disease) and myocardial infarction (irreversible injury to heart
muscles). Heart muscle strength is measure by the ejection fraction which is a
measure of the fraction of blood pumped out of the heart with each beat. A low
ejection fraction indicates a weak heart.
Several trials have been conducted involving patients
with enlarged weak heart muscles of unknown causes. For those of you who like
difficult phrases this condition (or variety of conditions) is known as
idiopathic dilated cardiomyopathy. In these trials CoQ10 supplementation was
compared to placebo effects. Standard treatments for heart failure were not
discontinued. The results were measured by echocardiography (a diagnostic test
which uses ultrasound waves to make images of the heart chambers, valves and
surrounding structures).
The overall results of CoQ10 supplementation
demonstrated a steady and continued improvement in heart function as well as
steady and continued reduction in patient symptoms including fatigue, chest
pains, palpitations and breathing difficulty. Patients with more establish and
long-term cases showed gradual improvement but did not gain normal heart
function. Patients with newer cases of heart failure demonstrated much more
rapid improvement often returning to normal heart function.
Papers numbering in the hundreds from eight different
symposia have been written and presented on the effects of CoQ10 on heart
disease. International clinical studies have also been conducted in the United
States, Japan, Germany, Italy and Sweden. Together these studies and the papers
that have been derived from them demonstrate significant improvement in heart
muscle function while causing no adverse effects.
One particular area of study involves diastolic
dysfunction which is one of the earliest signs of myocardial failure. Diastole
is the phase of the cardiac cycle when the heart is filled with returning
blood. Because this phase requires more cellular energy than the systolic phase
(when the blood is pushed out of the heart) it is more dependent on CoQ10.
Diastolic dysfunction is a stiffening of the heart muscle which naturally
restricts the heart's ability to pump. This condition is associated with many
cardiac disorders. Hypertension is among these disorders. As the heart muscles
become stiff there is often a corresponding rise in blood pressure. When the
diastolic dysfunction is reversed, blood pressure tends to lower as well.
In one study involving 109 patients with hypertension,
CoQ10 supplementation was added to normal hypertension treatments. In an
average of 4.4 months 51% of the patients were able stop using at least one
blood pressure lowering medication. Some were able to stop using up to three
medications. Another study produced similar results. In that study 43% of 424
patients were able to stop using between one and three cardiovascular drugs
because of CoQ10 supplementation.
These examples are just a drop in the bucket. Diastolic
dysfunction (and by proxy, hypertension) includes only a small sampling of
heart conditions that respond favorably to CoQ10 supplementation. Other areas
of research show great promise for CoQ10 treatments. Among these are cancer and
AIDS. But such conditions are beyond the scope of this essay. CoQ10 is
essential to the proper functioning of all cell types. It is not surprising, therefore,
to find a diverse number of diseases that respond favorably to CoQ10
supplementation. Since all metabolically active tissues are highly sensitive to
CoQ10 deficiency, we can expect to see CoQ10 research expanding to many other
areas of chronic diseases.
Greg holds degrees in science, divinity and philosophy
and is currently an I.T. developer.
[http://www.optimal-heart-health.com/coq10.html][http://www.optimal-heart-health.com/coq10.html]
You Can Build A Successful Website.
[http://www.make-your-own-website-wealth.com?referrer=optimal-heart-health.com]
Article Source:
[http://EzineArticles.com/?Treatment-of-Heart-Disease-with-Coenzyme-Q10&id=14240]
Treatment of Heart Disease with Coenzyme Q10

No comments:
Post a Comment